Novel Gene Signatures Predicting Primary Non-response to Infliximab in Ulcerative Colitis: Development and Validation Combining Random Forest With Artificial Neural Network.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: RF/ANN gene signature for primary infliximab nonresponse in UC; GSE16879 and GSE12251 training (n=46 total), independent GSE23597 validation (n=28), response assessed at 4/8 weeks using mucosal healing definition.
Technology: Learned gene signature predicts a specific treatment-response endpoint in independent public data; retrospective and small-cohort.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Learned gene signature predicts a specific treatment-response endpoint in independent public data; retrospective and small-cohort.
- Limitation / still unknown
- The gene signature was trained on 46 cases and checked in 28 independent cases; these small transcriptomic cohorts do not establish causal mechanisms or clinical utility.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.678424/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.